[Discussion on issues related to clinical experts consensus of Chinese patent medicine]

Zhongguo Zhong Yao Za Zhi. 2018 Dec;43(24):4792-4795. doi: 10.19540/j.cnki.cjcmm.20181009.003.
[Article in Chinese]

Abstract

The promulgation of standardized documents on traditional Chinese medicine has promoted the formulation of industrial standards of traditional Chinese medicine, including clinical practice guidelines and clinical expert consensus. In order to adapt to the current research situation of "insufficient evidence" or "very low quality" when developing clinical practice guideline in the field of traditional Chinese medicine, the author has made a retrospective study on the development of guidelines and consensus, and found that the consensus is more suitable for the current research status of Chinese patent medicine, as the stage of lack of high-quality clinical evidence will remain for a long time. However, unlike clinical practice guidelines, domestic scholars and consensus makers have insufficient understanding of the clinical experts consensus. This article will introduce the origin and status of the clinical experts consensus, the differences between clinical experts consensus and the clinical practice guidelines, and the basic principles that should be followed in the formulation of the clinical experts consensus of Chinese patent medicine, expecting to provide theory basis and reference for the normative formulation of clinical experts consensus.

Keywords: Chinese patent medicine; clinical experts consensus; traditional Chinese medicine.

MeSH terms

  • Consensus
  • Medicine, Chinese Traditional*
  • Nonprescription Drugs
  • Retrospective Studies

Substances

  • Nonprescription Drugs